Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fortinet Inc (FTNT) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Fortinet IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Fortinet Inc vs Health Care Select Sector SPDR Fund — how do they compare? Fortinet Inc trades at $191.41 (market cap $138.75B), while Health Care Select Sector SPDR Fund trades at $170.13 (market cap $43.48B). The key difference: Fortinet Inc is far larger — about 3.2× Health Care Select Sector SPDR Fund's market cap, and Fortinet Inc is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fortinet Inc for 72 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

FTNTXLV
Market Cap
$138.75B$43.48B
Volume
2,956,90811,121,431
Sector
Technology—
52-Week High
$191.27$175.68
52-Week Low
$75.23$141.95
Typical Hold Time
72 Days100 Days
Enterprise Value
$135.17B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fortinet Inc

FTNT trades at $189.28, down 1.04% on the day but near its 52-week high, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $6.80B in 2025, supported by an 80.2% gross margin and robust cash flow from operations of $2.59B. Analyst sentiment is mixed, with 42% buy ratings but a consensus price target of $158.64 below the current price.

Outlook remains positive due to cybersecurity demand and AI-driven growth, but high valuation ratios (P/E of 66.82) pose risks. Competition and execution challenges could pressure margins. Institutional interest is strong, with recent position increases noted in SEC filings. The stock's momentum depends on continued earnings outperformance and market share gains in data center security.

Health Care Select Sector SPDR Fund

XLV trades at $169.58 with a slight 0.46% daily gain amid bearish technical signals. The ETF faces selling pressure with moving averages indicating downward momentum while oscillators remain neutral. Recent news highlights XLV's competitive expense ratio of 0.08% and defensive healthcare sector positioning. Options activity shows increased put volume, suggesting some investor caution despite the fund's diversification across 61 healthcare stocks.

The healthcare ETF presents a cost-effective defensive play with potential upside if political volatility subsides post-elections. Key risks include sector-specific regulatory pressures and biotech trial failures impacting holdings. Current technical weakness near support at $166 requires monitoring for potential breakdown, though the fund's low fees and broad diversification provide stability during market uncertainty.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FTNT
77% Buy23% Sell
Avg holding period · 72 Days
XLV
53% Buy47% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About Fortinet Inc

Fortinet is a cybersecurity vendor that sells products, support, and services to small and midsize businesses, enterprises, and government entities. Its products include unified threat management appliances, firewalls, network security, and its security platform, Security Fabric. Services revenue is primarily from FortiGuard security subscriptions and FortiCare technical support. At the end of 2021, products were 38% of revenue and services were 62% of sales. The California-based company sells products worldwide.

Read more on FTNT →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →